Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Markers of blood-brain barrier disruption increase early and persistently in COVID-19 patients with neurological manifestations.
Bonetto V, Pasetto L, Lisi I, Carbonara M, Zangari R, Ferrari E, Punzi V, Luotti S, Bottino N, Biagianti B, Moglia C, Fuda G, Gualtierotti R, Blasi F, Canetta C, Montano N, Tettamanti M, Camera G, Grimoldi M, Negro G, Rifino N, Calvo A, Brambilla P, Biroli F, Bandera A, Nobili A, Stocchetti N, Sessa M, Zanier ER. Bonetto V, et al. Among authors: fuda g. Front Immunol. 2022 Dec 15;13:1070379. doi: 10.3389/fimmu.2022.1070379. eCollection 2022. Front Immunol. 2022. PMID: 36591311 Free PMC article.
Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72.
Chiò A, Borghero G, Restagno G, Mora G, Drepper C, Traynor BJ, Sendtner M, Brunetti M, Ossola I, Calvo A, Pugliatti M, Sotgiu MA, Murru MR, Marrosu MG, Marrosu F, Marinou K, Mandrioli J, Sola P, Caponnetto C, Mancardi G, Mandich P, La Bella V, Spataro R, Conte A, Monsurrò MR, Tedeschi G, Pisano F, Bartolomei I, Salvi F, Lauria Pinter G, Simone I, Logroscino G, Gambardella A, Quattrone A, Lunetta C, Volanti P, Zollino M, Penco S, Battistini S; ITALSGEN consortium; Renton AE, Majounie E, Abramzon Y, Conforti FL, Giannini F, Corbo M, Sabatelli M. Chiò A, et al. Brain. 2012 Mar;135(Pt 3):784-93. doi: 10.1093/brain/awr366. Brain. 2012. PMID: 22366794 Free PMC article.
Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for ALS.
Beghi E, Pupillo E, Bonito V, Buzzi P, Caponnetto C, Chiò A, Corbo M, Giannini F, Inghilleri M, Bella VL, Logroscino G, Lorusso L, Lunetta C, Mazzini L, Messina P, Mora G, Perini M, Quadrelli ML, Silani V, Simone IL, Tremolizzo L; Italian ALS Study Group. Beghi E, et al. Amyotroph Lateral Scler Frontotemporal Degener. 2013 Sep;14(5-6):397-405. doi: 10.3109/21678421.2013.764568. Epub 2013 Feb 19. Amyotroph Lateral Scler Frontotemporal Degener. 2013. PMID: 23421600 Clinical Trial.
Genetic counselling in ALS: facts, uncertainties and clinical suggestions.
Chiò A, Battistini S, Calvo A, Caponnetto C, Conforti FL, Corbo M, Giannini F, Mandrioli J, Mora G, Sabatelli M; ITALSGEN Consortium; Ajmone C, Mastro E, Pain D, Mandich P, Penco S, Restagno G, Zollino M, Surbone A. Chiò A, et al. J Neurol Neurosurg Psychiatry. 2014 May;85(5):478-85. doi: 10.1136/jnnp-2013-305546. Epub 2013 Jul 6. J Neurol Neurosurg Psychiatry. 2014. PMID: 23833266 Review.
Whole-blood global DNA methylation is increased in amyotrophic lateral sclerosis independently of age of onset.
Tremolizzo L, Messina P, Conti E, Sala G, Cecchi M, Airoldi L, Pastorelli R, Pupillo E, Bandettini Di Poggio M, Filosto M, Lunetta C, Agliardi C, Guerini F, Mandrioli J, Calvo A, Beghi E, Ferrarese C; EURALS Consortium. Tremolizzo L, et al. Amyotroph Lateral Scler Frontotemporal Degener. 2014 Mar;15(1-2):98-105. doi: 10.3109/21678421.2013.851247. Epub 2013 Nov 13. Amyotroph Lateral Scler Frontotemporal Degener. 2014. PMID: 24224837
Persistent idiopathic hypoglossal nerve palsy: A motor neuron disease-mimic syndrome?
Ilardi A, Moglia C, Cammarosano S, Canosa A, Bertuzzo D, Manera U, Fuda G, Chiò A, Calvo A. Ilardi A, et al. Among authors: fuda g. Amyotroph Lateral Scler Frontotemporal Degener. 2015 Jun;16(3-4):274-6. doi: 10.3109/21678421.2014.924144. Epub 2014 Jun 12. Amyotroph Lateral Scler Frontotemporal Degener. 2015. PMID: 24920472 No abstract available.
NADPH oxidase (NOX2) activity is a modifier of survival in ALS.
Marrali G, Casale F, Salamone P, Fuda G, Caorsi C, Amoroso A, Brunetti M, Restagno G, Barberis M, Bertuzzo D, Canosa A, Moglia C, Calvo A, Chiò A. Marrali G, et al. Among authors: fuda g. J Neurol. 2014 Nov;261(11):2178-83. doi: 10.1007/s00415-014-7470-0. Epub 2014 Sep 2. J Neurol. 2014. PMID: 25178511
Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study.
Lauria G, Dalla Bella E, Antonini G, Borghero G, Capasso M, Caponnetto C, Chiò A, Corbo M, Eleopra R, Fazio R, Filosto M, Giannini F, Granieri E, La Bella V, Logroscino G, Mandrioli J, Mazzini L, Monsurrò MR, Mora G, Pietrini V, Quatrale R, Rizzi R, Salvi F, Siciliano G, Sorarù G, Volanti P, Tramacere I, Filippini G; EPOS Trial Study Group. Lauria G, et al. J Neurol Neurosurg Psychiatry. 2015 Aug;86(8):879-86. doi: 10.1136/jnnp-2014-308996. Epub 2015 Jan 16. J Neurol Neurosurg Psychiatry. 2015. PMID: 25595151 Free PMC article. Clinical Trial.
70 results